ArticleRespiratory research2026

B cell activating factor (BAFF) levels are associated with failed remission after 12 months of treatment with benralizumab and mepolizumab in severe asthma.

Bettina Corinna Fischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.